When it comes to risk assessment and diagnosis of prenatal aneuploidy and pre-eclampsia, early detection is essential. Accurate results give women the confidence they need to plan and manage their pregnancies.
PerkinElmer supports laboratories and clinics with optimized screening solutions for all trimesters and a wide range of pregnancy complications. Through early assessment of pregnancy risks, we aim to improve the level of prenatal care.

• DELFIA® Xpress RANDOM ACCESS PLATFORM
• AutoDELFIA®
• VICTOR2D ™
• Vanadis® NIPT SYSTEM;

• GSP® INSTRUMENT
• QSight® 210 MD SCREENING SYSTEM
• TQD MSMS SCREENING SYSTEM
• EnLite™ NEONATAL TREC INSTRUMENT
• VICTOR2 ™D INSTRUMENT
• DBS PUNCHER®
• DELFIA® WASHER-DISKREMOVER
• AutoDELFIA®
• PANTHERA-PUNCHER™9

This kit is for the qualitative detection of human IgG antibodies to SARSCoV-2 in a dry drop sample of human blood or serum to aid in the identification of individuals with an adaptive immune response to SARSCoV-2, indicating a recent or previous infection.

• GSP®/DELFIA® Anti-SARS-CoV-2 IgG Kit